Literature DB >> 20002335

Smoking among women following heart transplantation: should we be concerned?

Lorraine Evangelista1, Alvina Ter-Galstanyan, Debra K Moser, Kathleen Dracup.   

Abstract

The serious detrimental effects of smoking after heart transplantation (HTX) are well established, but data that demonstrate the effects on female HTX recipients are scarce. The purpose of this study was to describe tobacco use, exposure to second hand smoke (ESHS), and health perceptions of female HTX recipients and examine relationships between these variables of interest and demographic and clinical characteristics of women following HTX. Seventy-two women (mean age, 54.3+/-12.7 years; mean time since transplant, 5.5+/-4.5 years) were enrolled from a single HTX center. Demographic and clinical data, tobacco use, ESHS, and health perceptions were obtained through self-report and chart reviews. Tobacco use was verified by measurement of urine cotinine levels. Twenty-four women were nonsmokers before and after HTX. Eighteen (37.5%) of the 48 women who were former smokers before HTX had returned to tobacco abuse. Only 4 of the 18 accurately reported their smoking behaviors. Forty percent of nonsmokers reported ESHS. Tobacco use and ESHS were highest among African American women. Forty percent of the sample perceived their health status as fair-poor; the remaining 60% reported good-excellent health. In a multivariate analysis, current tobacco use (odds ratio [OR], 5.20; confidence interval [CI], 3.83-9.13) and ESHS (OR, 1.82; CI, 1.17-2.82) were independent predictors of lower health perceptions. Although a majority of the female recipients who used tobacco ceased smoking before HTX, a substantial proportion demonstrated recurrent tobacco use after HTX. Our findings suggest the need for aggressive screening and risk factor interventions to promote smoking cessation before and after HTX in this unique population of female HTX recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002335      PMCID: PMC2892715          DOI: 10.1111/j.1751-7117.2009.00049.x

Source DB:  PubMed          Journal:  Prog Cardiovasc Nurs        ISSN: 0889-7204


  23 in total

1.  Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients.

Authors:  M R. Costanzo; H J. Eisen; R N. Brown; M Mehra; R Benza; G Torre; C W. Yancy; S Davis; M Mccloud; J Kirklin
Journal:  J Heart Lung Transplant       Date:  2001-02       Impact factor: 10.247

2.  Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities.

Authors:  Rosaly Correa-de-Araujo; Beth Stevens; Ernest Moy; David Nilasena; Francis Chesley; Kelly McDermott
Journal:  Womens Health Issues       Date:  2006 Mar-Apr

3.  Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers.

Authors:  Mandeep R Mehra; Patricia A Uber; Ananth Prasad; Robert L Scott; Myung H Park
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

4.  Self-rated health: changes, trajectories, and their antecedents among African Americans.

Authors:  Fredric D Wolinsky; Thomas R Miller; Theodore K Malmstrom; J Philip Miller; Mario Schootman; Elena M Andresen; Douglas K Miller
Journal:  J Aging Health       Date:  2008-01-11

Review 5.  Biological markers in smoking cessation treatment.

Authors:  C Lerman; C T Orleans; P F Engstrom
Journal:  Semin Oncol       Date:  1993-08       Impact factor: 4.929

6.  Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary?

Authors:  Stefan Störk; Thomas M Behr; Michael Birk; Peter Uberfuhr; Volker Klauss; Christoph H Spes; Christiane E Angermann
Journal:  J Heart Lung Transplant       Date:  2006-09       Impact factor: 10.247

7.  Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?

Authors:  Hiroo Takayama; Avery B Nathens; Heather Merry; Gabriel S Aldea; Daniel P Fishbein; Edward D Verrier; Christopher T Salerno
Journal:  Eur J Cardiothorac Surg       Date:  2007-01-30       Impact factor: 4.191

8.  Risk factors for smoking abuse after heart transplantation.

Authors:  A Basile; S Bernazzali; F Diciolla; F Lenzini; G Lisi; M Maccherini; V Mangini; E Nesti; M Chiavarelli
Journal:  Transplant Proc       Date:  2004-04       Impact factor: 1.066

Review 9.  Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease.

Authors:  Christopher Bullen
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-07

10.  Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry.

Authors:  Clyde W Yancy; William T Abraham; Nancy M Albert; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Lilin She; Jie Lena Sun; James B Young; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2008-04-29       Impact factor: 24.094

View more
  2 in total

Review 1.  Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.

Authors:  Patrick Hofmann; Christian Benden; Malcolm Kohler; Macé M Schuurmans
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Accuracy of self-reported tobacco use status among hematopoietic SCT patients.

Authors:  S L Ehlers; C A Bronars; C A Patten; T Brockman; C Hughes; P A Decker; J R Cerhan; W Hogan; A Dispenzieri; S Ansell; J Ebbert; D Gastineau
Journal:  Bone Marrow Transplant       Date:  2014-04-14       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.